Ifp Advisors, Inc Kura Oncology, Inc. Transaction History

Ifp Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$15.42 - $21.72 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$20.85 - $29.88 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$24.75 - $39.14 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	SELL	$29.0 - $41.62 $76,212 - $109,377	-2,628 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$16.3 - $30.64 $42,836 - $80,521	2,628 New	2,628 $81,000
Q1 2019 May 15, 2019	SELL	$13.73 - $16.87 $192 - $236	-14 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$16.65 - $21.85 $233 - $305	14 New	14 $0

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.